These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35863515)

  • 1. The role of imaging in targeted delivery of nanomedicine for cancer therapy.
    Li P; Wang D; Hu J; Yang X
    Adv Drug Deliv Rev; 2022 Oct; 189():114447. PubMed ID: 35863515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications.
    Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W
    Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles for tumor targeting delivery based on five features principle.
    Yong T; Wang D; Li X; Yan Y; Hu J; Gan L; Yang X
    J Control Release; 2020 Jun; 322():555-565. PubMed ID: 32246977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography image-guided drug delivery: current status and future perspectives.
    Chakravarty R; Hong H; Cai W
    Mol Pharm; 2014 Nov; 11(11):3777-97. PubMed ID: 24865108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Companion Diagnostic
    Lee H; Gaddy D; Ventura M; Bernards N; de Souza R; Kirpotin D; Wickham T; Fitzgerald J; Zheng J; Hendriks BS
    Theranostics; 2018; 8(9):2300-2312. PubMed ID: 29721081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
    Braga CB; Perli G; Becher TB; Ornelas C
    Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyrin-Based Nanomedicines for Cancer Treatment.
    Xue X; Lindstrom A; Li Y
    Bioconjug Chem; 2019 Jun; 30(6):1585-1603. PubMed ID: 31023011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging-guided revival of nanomedicine?
    Senders ML; Fayad ZA; Reiner T; Mulder WJ; Pérez-Medina C
    Nanomedicine (Lond); 2017 Jan; 12(2):89-90. PubMed ID: 27876441
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.
    Vallabani NVS; Singh S; Karakoti AS
    Curr Drug Metab; 2019; 20(6):457-472. PubMed ID: 30465498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.
    de Maar JS; Sofias AM; Porta Siegel T; Vreeken RJ; Moonen C; Bos C; Deckers R
    Theranostics; 2020; 10(4):1884-1909. PubMed ID: 32042343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using imaging modalities to predict nanoparticle distribution and treatment efficacy in solid tumors: The growing role of ultrasound.
    Cooley MB; Wegierak D; Exner AA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1957. PubMed ID: 38558290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of biophysical properties of tumor extracellular matrix on intratumoral fate of nanoparticles: Implications on the design of nanomedicine.
    Tian Y; Cheng T; Sun F; Zhou Y; Yuan C; Guo Z; Wang Z
    Adv Colloid Interface Sci; 2024 Apr; 326():103124. PubMed ID: 38461766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers.
    Yang J; Wang X; Wang B; Park K; Wooley K; Zhang S
    Adv Drug Deliv Rev; 2022 Nov; 190():114525. PubMed ID: 36100142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in nano/micro systems for improved circulation stability, enhanced tumor targeting, penetration, and intracellular drug delivery: a review.
    Chan WJ; Li H
    Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38086099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.